Diseases, Conditions, Syndromes

Study looks at treatment patterns for alopecia areata

For patients with alopecia areata (AA), corticosteroids are the most commonly used treatment, and by one year, 71.8 percent are receiving no treatment, according to a study published online Sept. 20 in JAMA Dermatology.

Diseases, Conditions, Syndromes

FDA approves Rinvoq for treatment of atopic dermatitis

The U.S. Food and Drug Administration approved Rinvoq (upadacitinib) for the treatment of moderate-to-severe atopic dermatitis in patients aged 12 years and older, the manufacturer announced Friday.

Medications

Topical corticosteroid use in pregnancy not tied to SGA, LBW

(HealthDay)—Topical corticosteroid use in pregnancy is not associated with increased risks for small for gestational age (SGA) or low birth weight, according to a study published online May 5 in JAMA Dermatology.

Health

Potent, unregulated steroid creams readily available in U.S.

(HealthDay)—Potent prescription-strength topical corticosteroids without a prescription (PSTCw/oP) are readily available in many U.S. cities, according to a letter to the editor published in the February issue of the Journal ...

page 1 from 3